Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Calumet Specialty Pr (NQ: CLMT )

16.96 -0.57 (-3.28%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 23, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 118,069
Open 17.64
Bid (Size) 16.25 (5)
Ask (Size) 17.50 (27)
Prev. Close 17.54
Today's Range 16.78 - 17.83
52wk Range 8.400 - 20.50
Shares Outstanding 78,676,262
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Earnings Scheduled For March 15, 2023
Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million. 
Via Benzinga
Earnings Preview: Calumet Specialty
 
Via Benzinga

Performance

YTD
+3.76%
+3.76%
1 Month
-13.04%
-13.04%
3 Month
+31.51%
+31.51%
6 Month
+5.64%
+5.64%
1 Year
+29.01%
+29.01%

More News

Read More
Looking Into Calumet Specialty's Return On Capital Employed
Via Benzinga
Wall Street Starts 2023 On Positive Note
Via Benzinga
Dow Falls 300 Points On Last Trading Session of 2022; S&P 500 Down 1%
Via Benzinga
Nasdaq Falls 100 Points; Dermata Therapeutics Shares Surge
Via Benzinga
Tesla And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
Via Benzinga
Cano Health, Aehr Test Systems, Credit Suisse And Other Big Gainers From Friday
Via Benzinga
7 Momentum Stocks to Buy Now for Extraordinary Gains
Via InvestorPlace
Calumet Specialty's Return On Capital Employed Overview
Via Benzinga
iRobot, Fox Factory, TripAdvisor And Some Other Big Gainers From Friday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 18, 2022
Via Benzinga
Nasdaq Falls Over 100 Points, Marker Therapeutics Shares Spike Higher
Via Benzinga
Why Quoin Pharmaceuticals Plunged Over 62%; Here Are 120 Biggest Movers From Friday
Via Benzinga
Why Cooper-Standard Is Trading Higher By 70%, Here Are 81 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Dow Drops 150 Points, Crude Oil Rises Over 2%
Via Benzinga
Markets Open Lower; U.S. Economy Adds Higher-Than-Expected Jobs In July
Via Benzinga
Recap: Calumet Specialty Q2 Earnings
Via Benzinga
Calumet Specialty's Earnings: A Preview
Via Benzinga
Dow Jumps More Than 200 Points; Samsung Sees This Much Surge In Quarterly Revenue
Via Benzinga
Earnings Scheduled For August 5, 2022
Via Benzinga
89 Biggest Movers From Friday
Via Benzinga
33 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Looking Into Calumet Specialty's Return On Capital Employed
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.